Related Experiment Video

Updated: Dec 25, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

And Now for Something Completely Different: Immunotherapy Beyond Checkpoints in Melanoma

Isabella Claudia Glitza1, Stephanie L Goff2, Merrick Ross3

  • 1Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|April 4, 2020
PubMed

Insights

Recent advances in melanoma immunotherapy, including cytokines, adoptive cell therapies (ADTs), and intratumoral injections, are improving cancer treatment outcomes. These strategies are paving the way for new developments in treating various solid tumors.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Melanoma treatment has seen rapid progress in the last 15 years.
  • Immunotherapy, particularly targeting immune checkpoints, has revolutionized cancer care.
  • Further research into diverse immunotherapeutic strategies is crucial for advancing patient outcomes.

Purpose of the Study:

  • To provide an updated overview of key immunotherapy advancements in melanoma treatment.
  • To highlight three specific areas of immunotherapy with significant clinical application and future potential.
  • To discuss the ongoing evolution of immunotherapeutic strategies beyond immune checkpoint inhibitors.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Focus on cytokines, adoptive cell therapies (ADTs), and intratumoral immunomodulatory agents.
  • Synthesis of current knowledge and emerging trends in melanoma immunotherapy.

Main Results:

  • Cytokines have demonstrated efficacy in modulating the immune response against melanoma.
  • Adoptive cell therapies (ADTs) offer personalized approaches to cancer treatment.
  • Intratumoral injections of immunomodulatory agents show promise in local tumor control and systemic immunity.

Conclusions:

  • Immunotherapy continues to be a rapidly evolving field in melanoma treatment.
  • Cytokines, ADTs, and intratumoral injections represent promising avenues for future therapeutic development.
  • These advancements in melanoma immunotherapy are setting precedents for treating other solid tumors.

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.2K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
872
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K